BlackRock Advisors’s Tetraphase Pharmaceuticals, Inc. TTPH Stock Holding History

BlackRock Advisors’s Portfolio TTPH Stock Details TTPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$76K	Sell	945 -25	-3%	-$1.98K	﹤0.01%	3142
2016 Q3	$74K	Buy	970 +146	+18%	+$11.7K	﹤0.01%	3143
2016 Q2	$71K	Hold	824	–	–	﹤0.01%	3115
2016 Q1	$76K	Hold	824	–	–	﹤0.01%	3042
2015 Q4	$165K	Sell	824 -355	-30%	-$70.8K	﹤0.01%	2670
2015 Q3	$176K	Sell	1,179 -21,318	-95%	-$15.6M	﹤0.01%	2799
2015 Q2	$21.3M	Buy	22,497 +9,412	+72%	+$7.7M	0.02%	510
2015 Q1	$9.59M	Buy	13,085 +12,416	+1,856%	+$9.33M	0.01%	797
2014 Q4	$531K	Buy	669 +111	+20%	+$59.8K	﹤0.01%	1957
2014 Q3	$223K	Sell	558 -4,338	-89%	-$1.16M	﹤0.01%	2547
2014 Q2	$1.32M	Buy	4,896 +90	+2%	+$19.3K	﹤0.01%	1331
2014 Q1	$1.05M	Buy	4,806 +223	+5%	+$62.1K	﹤0.01%	1498
2013 Q4	$1.24M	Buy	4,583 +1,337	+41%	+$319K	﹤0.01%	1381
2013 Q3	$739K	Buy	3,246 +1,185	+57%	+$207K	﹤0.01%	1624
2013 Q2	$290K	Buy	+2,061	New	+$326K	﹤0.01%	2233

Other funds holding TTPH

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

BlackRock Advisors's TTPH Position: Q4 2016 in Review

BlackRock Advisors reduced its Tetraphase Pharmaceuticals, Inc. (TTPH) stake by 2.6% in Q4 2016, selling an estimated $1.98K and leaving 945 shares worth $76K. The position accounts for ﹤0.01% of the portfolio, ranked #3142.

BlackRock Advisors first reported a position in TTPH in Q2 2013 and has held it in 15 quarters since. The position peaked at $21.3M in Q2 2015. 91 funds tracked by Wall St. Rank hold TTPH as of Q4 2016.

BlackRock Advisors held 945 shares of Tetraphase Pharmaceuticals, Inc. worth $76K as of Q4 2016.
BlackRock Advisors sold 25 Tetraphase Pharmaceuticals, Inc. shares in Q4 2016, an estimated $1.98K.
Tetraphase Pharmaceuticals, Inc. made up ﹤0.01% of BlackRock Advisors's portfolio in Q4 2016, its #3142 holding.
BlackRock Advisors first reported a position in Tetraphase Pharmaceuticals, Inc. in Q2 2013 and has held it in 15 quarters since.
BlackRock Advisors's Tetraphase Pharmaceuticals, Inc. position peaked at $21.3M in Q2 2015.
91 funds tracked by Wall St. Rank held Tetraphase Pharmaceuticals, Inc. as of Q4 2016.

Based on BlackRock Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.